0
Articles   |    
The Psychology of Hallucinogenic Drug Discontinuers
CARL SALZMAN; GERALD E. KOCHANSKY; RICHARD I. SHADER; JONATHAN LIEFF
Am J Psychiatry 1972;129:755-761.
View Article Information
Assistant Professor of Psychiatry, Psychopharmacology Research Laboratory, Massachusetts Mental Health Center, Boston, Mass. 02115
Assistant Professor of Psychology, Psychopharmacology Research Laboratory, Massachusetts Mental Health Center, Boston, Mass. 02115
Associate Professor of Psychiatry, Psychopharmacology Research Laboratory, Massachusetts Mental Health Center, Boston, Mass. 02115
Resident Psychiatrist, Boston State Hospital, Boston, Mass.
An erratum to this article has been published | view the erratum
text A A A
PDF of the full text article.
Abstract
Psychological test data from individuals who had discontinued using hallucinogens with those from individuals who were still using them were compared. While the continuers had a tendency toward higher risk-taking behavior, the two samples could not be otherwise psychologically differentiated. Between two subsamples with moderate drug experience, the continuers showed a greater trend toward psychiatric impairment than the discontinuers. The authors do not believe that drug experiences impaired the discontinuers.Abstract Teaser
Figures in this Article

    Topics

    hallucinogen
    Your Session has timed out. Please sign back in to continue.
    Sign In Your Session has timed out. Please sign back in to continue.
    Sign In to Access Full Content
     
    Username
    Password
    Sign in via Athens (What is this?)
    Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
    Not a subscriber?

    Subscribe Now/Learn More

    PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

    +
    +
    +

    CME Activity

    There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
    Submit a Comments
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe



    Related Content
    Articles
    Books
    Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 15.  >
    The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 13.  >
    The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 14.  >
    The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 40.  >
    Psychiatric News
    PubMed Articles
    Clearing the smoke around medical marijuana.
    Clinical pharmacology and therapeutics 2011 Dec
    Cannabinoid-opioid interaction in chronic pain.
    Clinical pharmacology and therapeutics 2011 Dec